search
Back to results

Mechanism-based Choice of Therapy for Pain: Can Successful Prevention of Migraine be Coupled to a Psychophysical Pain Modulation Profile?

Primary Purpose

Migraine

Status
Completed
Phase
Not Applicable
Locations
Israel
Study Type
Interventional
Intervention
Amitriptyline
Topiramate
Sponsored by
Rambam Health Care Campus
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Migraine focused on measuring migraine patients

Eligibility Criteria

18 Years - 75 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • female and male migraine patients with a number of month attacks ≥ 4,
  • age 18-75,
  • without any other chronic pain.

Exclusion Criteria:

  • any migraine preventive treatment for last 6 month & psychiatric,
  • language or cognitive dysfunction precluding use of psychophysics.

Sites / Locations

  • Rambam Medical Center

Arms of the Study

Arm 1

Arm 2

Arm Type

Active Comparator

Active Comparator

Arm Label

1 Amitriptyline.

2 Topiramate

Arm Description

Amitriptyline

Topiramate

Outcomes

Primary Outcome Measures

Therapeutic response to the analgesic drugs

Secondary Outcome Measures

Full Information

First Posted
July 10, 2010
Last Updated
October 10, 2017
Sponsor
Rambam Health Care Campus
search

1. Study Identification

Unique Protocol Identification Number
NCT01161017
Brief Title
Mechanism-based Choice of Therapy for Pain: Can Successful Prevention of Migraine be Coupled to a Psychophysical Pain Modulation Profile?
Official Title
Mechanism-based Choice of Therapy for Pain: Can Successful Prevention of Migraine be Coupled to a Psychophysical Pain Modulation Profile?
Study Type
Interventional

2. Study Status

Record Verification Date
October 2017
Overall Recruitment Status
Completed
Study Start Date
July 2008 (Actual)
Primary Completion Date
May 2014 (Actual)
Study Completion Date
May 2014 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Rambam Health Care Campus

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
Mechanism-based choice of therapy for pain: Can successful prevention of migraine be coupled to a psychophysical pain modulation profile?

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Migraine
Keywords
migraine patients

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
ParticipantCare ProviderInvestigator
Allocation
Randomized
Enrollment
67 (Actual)

8. Arms, Groups, and Interventions

Arm Title
1 Amitriptyline.
Arm Type
Active Comparator
Arm Description
Amitriptyline
Arm Title
2 Topiramate
Arm Type
Active Comparator
Arm Description
Topiramate
Intervention Type
Drug
Intervention Name(s)
Amitriptyline
Intervention Description
Initial dose of 12.5mg will be given for 2 days. Then, daily 25mg will be taken for additional 8 weeks
Intervention Type
Drug
Intervention Name(s)
Topiramate
Intervention Description
For the first 5 days of treatment 25mg is prescribed and should be ingested in one evening dose. For another 5 days, 25g dose should be taken twice a day (morning and evening). For the next 5 days, morning dose will be 25mg; evening dose will be 50mg. For the remaining 6 weeks of treatment, a dose of 50mg twice a day will be advised
Primary Outcome Measure Information:
Title
Therapeutic response to the analgesic drugs
Time Frame
2 months

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
75 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: female and male migraine patients with a number of month attacks ≥ 4, age 18-75, without any other chronic pain. Exclusion Criteria: any migraine preventive treatment for last 6 month & psychiatric, language or cognitive dysfunction precluding use of psychophysics.
Facility Information:
Facility Name
Rambam Medical Center
City
Haifa
Country
Israel

12. IPD Sharing Statement

Learn more about this trial

Mechanism-based Choice of Therapy for Pain: Can Successful Prevention of Migraine be Coupled to a Psychophysical Pain Modulation Profile?

We'll reach out to this number within 24 hrs